SEARCH

SEARCH BY CITATION

References

  • 1
    Capen CC, Martin SL, Koestner A. Neoplasms in the adenohypophysis of dogs. Path Vet 1967;4:301325.
  • 2
    Ling GV, Stabenfeldt GH, Comer KM, et al. Canine hyperadrenocorticism: Pretreatment clinical and laboratory evaluation of 117 cases. J Am Vet Med Assoc 1979;174:12111215.
  • 3
    Neiger R, Ramsey IK, O'Conner J, et al. Trilostane treatment of 78 dogs with pituitary-dependent hyperadrenocorticism. Vet Rec 2002;150:799804.
  • 4
    Owens JM, Drucker WD. Hyperadrenocorticism in the dog: Canine Cushing's syndrome. Vet Clin North Am 1977;7:583602.
  • 5
    Peterson ME, Krieger DT, Drucker WD. Immunocytochemical study of the hypophysis in 25 dogs with pituitary-dependent hyperadrenocorticism. Acta Endocrinol 1982;101:1524.
  • 6
    Reusch CE, Feldman EC. Canine hyperadrenocorticism due to adrenocortical neoplasia. Pretreatment evaluation of 41 dogs. J Vet Int Med 1991;5:310.
  • 7
    Ruckstuhl NS, Nett CS, Reusch C. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Am J Vet Res 2002;63:506512.
  • 8
    Scavelli TD, Peterson ME, Matthiesen DT. Results of surgical treatment for hyperadrenocorticism caused by adrenocortical neoplasia in the dog: 25 cases (1980–1984). J Am Vet Med Assoc 1986;189:13601364.
  • 9
    Schechter RD, Stabenfeldt GH, Gribble DH, Ling GV. Treatment of Cushing's syndrome in the dog with an adrenocorticolytic agent (o, p'DDD). J Am Vet Med Assoc 1973;162:629639.
  • 10
    Reusch C, Steffen T, Hoerauf A. The efficacy of L-deprenyl in dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 1999;13:291301.
  • 11
    Zur G, White SD. Hyperadrenocorticism in 10 dogs with skin lesions as the only presenting clinical signs. J Am Anim Hosp Assoc 2011;47:419427.
  • 12
    Rewarts JM, Grooters AM, Payne JT, Kornegay JN. A traumatic rupture of the gastrocnemius muscle after corticosteroid administration in a dog. J Am Vet Med Assoc 1997;210:655657.
  • 13
    Swinney GR, Foster SF, Church DB, Malik R. Myotonia associated with hyperadrenocorticism in two dogs. Aust Vet J 1998;76:722724.
  • 14
    Greene CE, Lorenz MD, Munnell JF, et al. Myopathy associated with hyperadrenocorticism in the dog. J Am Vet Med Assoc 1979;174:13101315.
  • 15
    Feldman BF, Rasedee A, Feldman EC. Haemostatic abnormalities in canine Cushing's syndrome. Res Vet Sci 1986;41:228230.
  • 16
    Burns MG, Kelly AB, Hornof WJ, Howerth EW. Pulmonary artery thrombosis in three dogs with hyperadrenocorticism. J Am Vet Med Assoc 1981;178:388393.
  • 17
    Blaxter AC, Gruffydd-Jones TJ. Concurrent diabetes mellitus and hyperadrenocorticism in the dog: Diagnosis and management of eight cases. J Small Anim Pract 1990;31:117122.
  • 18
    Peterson ME, Nesbitt GH, Schaer M. Diagnosis and management of concurrent diabetes mellitus and hyperadrenocorticism in 30 dogs. J Am Vet Med Assoc 1981;178:6669.
  • 19
    Lang JM, Schertel E, Kennedy S, et al. Elective and emergency surgical management of adrenal gland tumors: 60 cases (1999–2006). J Am Anim Hosp Assoc 2011;47:428435.
  • 20
    Vandenbergh AGGD, Voorhout G, van Sluijs FJ, et al. Haemorrhage from a canine adrenocortical tumour: A clinical emergency. Vet Rec 1992;131:539540.
  • 21
    Kaplan AJ, Peterson ME, Kemppainen RJ. Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs. J Am Vet Med Assoc 1995;207:445451.
  • 22
    Chastain CB, Franklin RT, Ganjam VK, Madsen RW. Evaluation of the hypothalamic pituitary-adrenal axis in clinically stressed dogs. J Am Anim Hosp Assoc 1986;22:435442.
  • 23
    Kemppainen RJ, Sartin JL. Evidence for episodic but not circadian activity in plasma concentrations of adrenocorticotrophin, cortisol and thyroxine in dogs. J Endocrinol 1984;103:219226.
  • 24
    Eiler H, Oliver JW, Legendre AM. Stages of hyperadrenocorticism: Response of hyperadrenocorticoid dogs to the combined dexamethasone suppression/ACTH stimulation test. J Am Vet Med Assoc 1984;185:289294.
  • 25
    Church DB, Nicholson AI, Ilkiw JE, Emslie DR. Effect of non-adrenal illness, anasthesia and surgery on plasma cortisol concentrations in dogs. Res Vet Sci 1994;56:129131.
  • 26
    Behrend EN, Kemppainen RJ, Young DW. Effect of storage conditions on cortisol, total thyroxine and free thyroxine concentrations in serum and plasma of dogs. J Am Vet Med Assoc 1995;212:15641568.
  • 27
    Ambrogio AG, Pecori GF, Cavagnini F. Drugs and HPA axis. Pituitary 2008;11:219229.
  • 28
    Zeugswetter F, Hoyer MT, Pagitz M, et al. The desmopressin stimulation test in dogs with Cushing's syndrome. Domest Anim Endocrinol 2008;34:254260.
  • 29
    Selman PJ, Mol JA, Rutteman GR, et al. Effects of progestin administration on the hypothalamic-pituitary-adrenal axis and glucose homeostasis in dogs. J Reprod Fertil Supp 1997;51:345354.
  • 30
    Feldman EC, Nelson RW. Glucocorticoid therapy. In: Feldman EC, Nelson RW, eds. Canine and Feline Endocrinology and Reproduction. St. Louis, MO: Saunders; 2004:465538.
  • 31
    Lothrop CD, Oliver J. Diagnosis of canine Cushing's syndrome based on multiple steroid analyses and dexamethasone turnover kinetics. Am J Vet Res 1984;45:23042309.
  • 32
    Kooistra HS, Voorhout G, Mol JA, Rijnberk A. Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. J Endocrinol 1997;152:387394.
  • 33
    Findling JW, Raff H, Aron DC. The low-dose dexamethasone suppression test: A re-evaluation in patients with Cushing's syndrome. J Clin Endocrinol Metab 2004;89:12221226.
  • 34
    Boscaro M, Arnaldi G. Approach to the patient with possible Cushing's syndrome. J Clin Endocrinol Metab 2009;94:31213131.
  • 35
    Feldman EC, Feldman MS, Nelson RW. Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs. J Am Vet Med Assoc 1996;209:772775.
  • 36
    Feldman EC. Comparison of ACTH response and dexamethasone suppression as screening tests in canine hyperadrenocorticism. J Am Vet Med Assoc 1983;182:506510.
  • 37
    Meijer JC, de Bruijne JJ, Rijnberk A, Croughs RJM. Biochemical characterization of pituitary-dependent hyperadrenocorticism in the dog. J Endocrinol 1978;77:111118.
  • 38
    Meijer JC, Lubberink AAME, Rijnberk A, Croughs JM. Adrenocortical function tests in dogs with hyperfunctioning adrenocortical tumors. J Endocrinol 1979;80:315319.
  • 39
    Mack RE, Feldman EC. Comparison of two low-dose dexamethasone suppression protocols as screening and discrimination tests in dogs with hyperadrenocorticism. J Am Vet Med Assoc 1990;197:16031606.
  • 40
    May ER, Frank LA, Hnilica KA, Lane IF. Effects of a mock ultrasonographic procedure on cortisol concentrations during low-dose dexamethasone suppression testing in clinically normal adult dogs. Am J Vet Res 2004;65:267270.
  • 41
    Mueller C, Sieber-Ruckstuhl N, Wenger M, et al. Low-dose dexamethasone test with “inverse” results: A possible new pattern of cortisol response. Vet Rec 2006;159:489491.
  • 42
    Rijnberk A, van Wees A, Mol JA. Assessment of two tests for the diagnosis of canine hyperadrenocorticism. Vet Rec 1988;122:178180.
  • 43
    van Liew CH, Greco DS, Salman MD. Comparison of results of adrenocorticotropic hormone stimulation and low-dose dexamethasone suppression test with necropsy findings in dogs: 81 cases (1985–1995). J Am Vet Med Assoc 1997;211:322325.
  • 44
    Kemppainen RJ, Sartin JL. Effects of single intravenous doses of dexamethasone on baseline plasma cortisol concentrations and response to synthetic ACTH in healthy dogs. Am J Vet Res 1984;45:742746.
  • 45
    Chauvet AE, Feldman EC, Kass PS. Effects of phenobarbital administration on results of serum biochemical analyses and adrenocortical function tests in epileptic dogs. J Am Vet Med Assoc 1995;207:13051307.
  • 46
    Muller PB, Wolfsheimer KJ, Taboada J, et al. Effects of long-term phenobarbital treatment on the thyroid and adrenal axis and adrenal function tests in dogs. J Vet Intern Med 2000;14:157164.
  • 47
    Foster SF, Church DB, Watson ADJ. Effect of phenobarbitone on the low-dose dexamethasone suppression test and the urinary corticoid:creatinine ratio in dogs. Aust Vet J 2000;78:1923.
  • 48
    Behrend EN, Kemppainen RJ, Boozer AL, et al. Serum 17-α-hydroxyprogesterone and corticosterone concentrations in dogs with non-adrenal neoplasia and dogs with suspected hyperadrenocorticism. J Am Vet Med Assoc 2005;227:17621767.
  • 49
    Gieger TL, Feldman EC, Wallack ST, Dank G. Lymphoma as a model for chronic illness: Effects on adrenocortical function testing. J Vet Intern Med 2003;17:154157.
  • 50
    Peterson ME, Gilbertson SR, Drucker WD. Plasma cortisol response to exogenous ACTH in 22 dogs with hyperadrenocorticism caused by adrenocortical neoplasia. J Am Vet Med Assoc 1982;180:542544.
  • 51
    Monroe WE, Panciera DL, Zimmerman KL. Concentrations of noncortisol adrenal steroids in response to ACTH in dogs with adrenal-dependent hyperadrenocorticism, pituitary-dependent hyperadrenocorticism, and nonadrenal illness. J Vet Intern Med 2012;26:945952.
  • 52
    Cohen TA, Feldman EC. Comparison of IV and IM formulations of synthetic ACTH for ACTH stimulation tests in healthy dogs. J Vet Intern Med 2012;26:412414.
  • 53
    Kemppainen RJ, Behrend EN, Busch KA. Use of compounded adrenocorticotropic hormone (ACTH) for adrenal function testing in dogs. J Am Anim Hosp Assoc 2005;41:368372.
  • 54
    Hansen BL, Kemppainen RJ, MacDonald JM. Synthetic ACTH (Cosyntropin) stimulation tests in normal dogs: Comparison of intravenous and intramuscular administration. J Am Anim Hosp Assoc 1994;30:3841.
  • 55
    Behrend EN, Kemppainen RJ, Bruyette DS, et al. Intramuscular administration of a low dose of ACTH for ACTH stimulation testing in dogs. J Am Vet Med Assoc 2006;229:528530.
  • 56
    Kerl ME, Peterson ME, Wallace MS, et al. Evaluation of a low-dose synthetic adrenocorticotropic hormone stimulation test in clinically normal dogs and dogs with naturally developing hyperadrenocorticism. J Am Vet Med Assoc 1999;214:14971501.
  • 57
    Frank LA, DeNovo RC, Kraje AC, Oliver J. Cortisol concentrations following stimulation of healthy and adrenopathic dogs with two doses of tetracosactrin. J Small Anim Pract 2000;41:308311.
  • 58
    Martin LG, Behrend EN, Mealey KL, et al. Effect of low doses of cosyntropin on serum cortisol concentrations in clinically normal dogs. Am J Vet Res 2007;68:555560.
  • 59
    Ginel PJ, Sileo PJ, Blanco B, et al. Evaluation of serum concentrations of cortisol and sex hormones of adrenal gland origin after stimulation with two synthetic ACTH preparations in clinically normal dogs. Am J Vet Res 2012;73:237241.
  • 60
    Frank LA, Oliver J. Comparison of serum cortisol concentrations in clinically normal dogs after administration of freshly reconstituted versus reconstituted and stored frozen cosyntropin. J Am Vet Med Assoc 1998;212:15691571.
  • 61
    Willard MD, Nachreiner R, McDonald R, Roudebush P. Ketoconazole-induced changes in selected canine hormone concentrations. Am J Vet Res 1986;47:25042509.
  • 62
    Dyer KR, Monroe WE, Forrester SD. Effects of short- and long-term administration of phenobarbital on endogenous ACTH concentration and the results of ACTH stimulation tests in dogs. J Am Vet Med Assoc 1994;205:315318.
  • 63
    Smiley LE, Peterson ME. Evaluation of a urine cortisol:creatinine ratio as a screening test for hyperadrenocorticism in dogs. J Vet Int Med 1993;7:163168.
  • 64
    Feldman EC, Mack RE. Urine cortisol:creatinine ratio as a screening test for hyperadrenocorticism in dogs. J Am Vet Med Assoc 1992;200:16371641.
  • 65
    Stolp R, Rijnberk A, Meijer JC, Croughs JM. Urinary corticoids in the diagnosis of canine hyperadrenocorticism. Res Vet Sci 1983;34:141144.
  • 66
    Jensen AL, Iverson L, Koch J, et al. Evaluation of the urinary cortisol:creatinine ratio in the diagnosis of hyperadrenocorticism in dogs. J Small Anim Pract 1997;38:99102.
  • 67
    van Vonderen IK, Kooistra HS, Rijnberk A. Influence of veterinary care on the urinary corticoid:creatinine ratio in dogs. J Vet Intern Med 1998;12:431435.
  • 68
    Zeugswetter F, Bydzovsky N, Kampner D, Schwendenwein I. Tailored reference limits for urine corticoid:creatinine ratio in dogs to answer distinct clinical questions. Vet Rec 2010;167:9971001.
  • 69
    Galac S, Kooistra HS, Voorhout G, et al. Hyperadrenocorticism in a dog due to ectopic secretion of adrenocorticotropic hormone. Domest Anim Endocrinol 2005;28:338348.
  • 70
    Galac S, Kars VJ, Voorhout G, et al. ACTH-independent hyperadrenocorticism due to food-dependent hypercortisolemia in a dog: A case report. Vet J 2007;177:141143.
  • 71
    Kooistra HS, Greven SH, Mol JA, Rijnberk A. Pulsatile secretion of alpha-MSH and the differential effects of dexamethasone and haloperidol on the secretion of alpha-MSH and ACTH in dogs. J Endocrinol 1997;152:113121.
  • 72
    Castillo V, Blatter C, Gomez NV, et al. Diurnal ACTH and plasma cortisol variations in healthy dogs and in those with pituitary-dependent Cushing's syndrome before and after treatment with retinoic acid. Res Vet Sci 2009;86:223229.
  • 73
    Hanson JM, Kooistra HS, Mol JA, et al. Plasma profiles of adenocorticotropic hormone, cortisol, alpha-melanocyte-stimulating hormone, and growth hormone in dogs with pituitary-dependent hyperadrenocorticism before and after hypophysectomy. J Endocrinol 2006;190:601609.
  • 74
    Kemppainen RJ, Clark TP, Peterson ME. Preservative effect of aprotinin on canine plasma immunoreactive adrenocorticotropin concentrations. Domest Anim Endocrinol 1993;11:355362.
  • 75
    Rodriguez Pineiro MI, Benchekroun G, de Fornel-Thibaud P, et al. Accuracy of an adrenocorticotropic hormone (ACTH) immunoluminometric assay for differentiating ACTH-dependent from ACTH-independent hyperadrenocorticism in dogs. J Vet Intern Med 2009;23:850855.
  • 76
    Scott-Moncrieff JCR, Koshko M, Brown JA, et al. Validation of chemiluminescent enzyme immunometric assay for plasma adrenocorticotropic hormone in the dog. Vet Clin Pathol 2003;32:180187.
  • 77
    Zeugswetter F, Pagitz M, Hittmair K, Schwendenwein I. Diagnostic efficacy of plasma ACTH-measurement by a chemiluminometric assay in canine hyperadrenocorticism. Schweiz Arch Tierheilkd 2011;153:111116.
  • 78
    Hegstad RL, Johnston SD, Pasternak DM. Effects of sample handling on adrenocorticotropin concentration measured in canine plasma, using a commercially available radioimmunoassay kit. Am J Vet Res 1990;51:19411947.
  • 79
    Bosje JT, Rijnberk A, Mol JA, et al. Plasma concentrations of ACTH precursors correlate with pituitary size and resistance to dexamethasone in dogs with pituitary-dependent hyperadrenocorticism. Domest Anim Endocrinol 2002;22:201210.
  • 80
    Galac S, Kooistra HS, Teske E, Rijnberk A. Urinary corticoid/creatinine ratios in the differentiation between pituitary-dependent hyperadrenocorticism and hyperadrenocorticism due to adrenocortical tumor in the dog. Vet Quart 1997;19:1720.
  • 81
    Galac S, Buijtels JJCWM, Kooistra HS. Urinary corticoid:creatinine ratios in dogs with pituitary-dependent hypercortisolism during trilostane treatment. J Vet Intern Med 2009;23:12141219.
  • 82
    Kemppainen RJ, Peterson ME. Circulating concentration of dexamethasone in healthy dogs, dogs with hyperadrenocorticism, and dogs with nonadrenal illness during dexamethasone suppression testing. Am J Vet Res 1993;54:17651769.
  • 83
    Berry CR, Hawkins EC, Hurley KJ, Monce K. Frequency of pulmonary mineralization and hypoxemia in 21 dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 2000;14:151156.
  • 84
    Schwarz T, Stork CK, Mellor D, Sullivan M. Osteopenia and other radiographic signs in canine hyperadrenocorticism. J Small Anim Pract 2000;41:491495.
  • 85
    Voorhout G, Rijnberk A, Sjollema BE, van den Ingh TSGAM. Nephrotomography and ultrasonography for the localization of hyperfunctioning adrenocortical tumors in dogs. Am J Vet Res 1990;51:12801285.
  • 86
    Hoerauf A, Reusch C. Ultrasonographic characteristics of both adrenal glands in 15 dogs with funtional adrenocortical tumors. J Am Anim Hosp Assoc 1999;35:193199.
  • 87
    Grooters AM, Biller DS, Theisen SK, Miyabayashi T. Ultrasonographic characteristics of the adrenal glands in dogs with pituitary-dependent hyperadrenocorticism: Comparison with normal dogs. J Vet Intern Med 1996;10:110115.
  • 88
    Rodriguez Pineiro MI, de Fornel-Thibaud P, Benchekroun G, et al. Use of computed tomography adrenal gland measurement for differentiating ACTH dependence from ACTH independence in 64 dogs with hyperadenocorticism. J Vet Intern Med 2011;25:10661074.
  • 89
    Benchekroun G. Ultrasonography criteria for differentiating ACTH dependency from ACTH independency in 47 dogs with hyperadrenocorticism and equivocal adrenal asymmetry. J Vet Intern Med 2010;24:10771085.
  • 90
    Ford SL, Feldman EC, Nelson RW. Hyperadrenocorticism caused by bilateral adrenocortical neoplasia in dogs: Four cases (1983–1988). J Am Vet Med Assoc 1993;202:789792.
  • 91
    van Sluijs FJ, Sjollema BE, Voorhout G, et al. Results of adrenalectomy in 36 dogs with hyperadrenocorticism caused by adrenocortical tumor. Vet Quart 1995;17:113116.
  • 92
    Schultz RM, Wisner ER, Johnson EG, MacLeod JS. Contrast-enhanced computed tomography as a preoperative indicator of vascular invasion from adrenal masses in dogs. Vet Radiol Ultrasound 2009;50:625629.
  • 93
    Kipperman BS, Feldman EC, Dybdal NO, Nelson RW. Pituitary tumor size, neurologic signs, and relation to endocrine test results in dogs with pituitary-dependent hyperadrenocorticism: 43 cases (1980–1990). J Am Vet Med Assoc 1992;201:762767.
  • 94
    Bertoy EH, Feldman EC, Nelson RW, et al. Magnetic resonance imaging of the brain in dogs with recently diagnosed but untreated pituitary-dependent hyperadrenocorticism. J Am Vet Med Assoc 1995;206:651656.
  • 95
    van der Vlugt-Meijer RH, Voorhout G, Meij BP. Imaging of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. Mol Cell Endocrinol 2002;197:8187.
  • 96
    Auriemma E, Barthez PY, van der Vlugt-Meijer RH, et al. Computed tomography and low-magnetic resonance imaging of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism: 11 cases (2001–2003). J Am Vet Med Assoc 2009;235:409414.
  • 97
    van der Vlugt-Meijer RH, Meij BP, van den Ingh TSGAM, et al. Dynamic computed tomography of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 2003;17:773780.
  • 98
    Taoda T, Hara Y, Masuda H, et al. Magnetic resonance imaging assessment of pituitary posterior lobe displacement in dogs with pituitary-dependent hyperadrenocorticism. J Vet Med Sci 2011;73:725731.
  • 99
    Greco DS, Peterson ME, Davidson AP, et al. Concurrent pituitary and adrenal tumors in dogs with hyperadrenocorticism: 17 cases (1978–1995). J Am Vet Med Assoc 1999;214:13491353.
  • 100
    Behrend EN, Kennis RA. Atypical Cushing's syndrome in dogs: Arguments for and against. Vet Clin North Am Small Anim Pract 2010;40:285296.
  • 101
    Ristic JME, Ramsey IK, Heath FM, et al. The use of 17-hydroxyprogesterone in the diagnosis of canine hyperadrenocorticism. J Vet Intern Med 2002;16:433439.
  • 102
    Benitah N, Feldman EC, Kass PH, Nelson RW. Evaluation of serum 17-hydroxyprogesterone concentration after administration of ACTH in dogs with hyperadrenocorticism. J Am Vet Med Assoc 2005;227:10951101.
  • 103
    Syme HM, Scott-Moncrieff JCR, Treadwell NG, et al. Hyperadrenocorticism associated with excessive sex hormone production by an adrenocortical tumor in two dogs. J Am Vet Med Assoc 2001;219:17251728.
  • 104
    Norman EJ, Thompson H, Mooney CT. Dynamic adrenal function testing in eight dogs with hyperadrenocorticism associated with adrenocortical neoplasia. Vet Rec 1999;144:551554.
  • 105
    Zimmerman KL, Panciera DL, Panciera RJ, et al. Hyperphosphatasemia and concurrent adrenal gland dysfunction in apparently healthy Scottish Terriers. J Am Vet Med Assoc 2010;237:178186.
  • 106
    Reine NJ, Hohenhaus AE, Peterson ME, Patnaik AK. Deoxycorticosterone-secreting adrenocortical carcinoma in a dog. J Vet Intern Med 1999;13:386390.
  • 107
    Hill KE, Scott-Moncrieff JCR, Koshko M, et al. Secretion of sex hormones in dogs with adrenal dysfunction. J Am Vet Med Assoc 2005;226:556561.
  • 108
    Oliver J. Steroid profiles in the diagnosis of canine adrenal disorders. Proc 25th Ann Vet Med Forum 2007:471473.
  • 109
    Chapman PS, Mooney CT, Ede J, et al. Evaluation of the basal and post-adrenocorticotrophic hormone serum concentrations of 17-hydroxyprogesterone for the diagnosis of hyperadrenocorticism in dogs. Vet Rec 2003;153:771775.
  • 110
    Huizenga NA, Koper JW, De Lange P, et al. A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 1998;83:144151.
  • 111
    Ortega TM, Feldman EC, Nelson RW, et al. Systemic arterial blood pressure and urine protein/creatinine ratio in dogs with hyperadrenocorticism. J Am Vet Med Assoc 1996;209:17241729.
  • 112
    Goy-Thollot I, Pechereau D, Keroack S, et al. Investigation of the role of aldosterone in hypertension associated with spontaneous pituitary-dependent hyperadrenocorticism in dogs. J Small Anim Pract 2002;43:489492.
  • 113
    Lien YH, Hsiang TY, Huang HP. Associations among systemic blood pressure, microalbuminuria and albuminuria in dogs affected with pituitary- and adrenal-dependent hyperadrenocorticism. Acta Vet Scand 2010;52:61.
  • 114
    Gould SM, Baines EA, Mannion PA, et al. Use of endogenous ACTH concentration and adrenal ultrasonography to distinguish the cause of canine hyperadrenocorticism. J Small Anim Pract 2001;42:113121.